Following publication of these new study results, Lilly indicated that it anticipates the Food and Drug Administration will make a regulatory decision as early as the end of this year. Industry analysts expect that makers of other weight-loss drugs will soon turn their attention to OSA, too
Rybelsus: store at room temperature (6877F / 2025C) in the original package, away from moisture
Propensity-score matching was applied to control for baseline differences between cohorts, ensuring comparability
User 21 is a cautionary case: his first vial worked, but his next two caused diarrhea, dizziness, nausea, and headaches
In the interim, these findings may help inform clinicianpatient discussions regarding the ocular safety profile of GLP-1 receptor agonists in individuals with type 2 diabetes who are at elevated vascular risk